Why is Shanghai Hile Bio-Technology Co., Ltd. ?
1
- PRE-TAX PROFIT(Q) At CNY 6.12 MM has Fallen at -89.46%
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.91 times
- NET SALES(Q) Lowest at CNY 39.97 MM
2
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -33.85% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Hile Bio-Technology Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai Hile Bio-Technology Co., Ltd.
-57.34%
-0.94
34.13%
China Shanghai Composite
23.91%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
-10.64%
EBIT Growth (5y)
27.57%
EBIT to Interest (avg)
1.32
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.17
Tax Ratio
13.73%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.79%
ROE (avg)
6.32%
Valuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
2.42
EV to EBIT
53.22
EV to EBITDA
37.14
EV to Capital Employed
3.17
EV to Sales
10.61
PEG Ratio
0.12
Dividend Yield
2.36%
ROCE (Latest)
5.96%
ROE (Latest)
37.48%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
8What is working for the Company
NET PROFIT(HY)
Higher at CNY 310.79 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -33.48 %
-19What is not working for the Company
NET SALES(HY)
At CNY 85.52 MM has Grown at -45.29%
PRE-TAX PROFIT(Q)
At CNY 9.17 MM has Fallen at -91.83%
NET PROFIT(Q)
At CNY 6.35 MM has Fallen at -92.12%
ROCE(HY)
Lowest at -25.66%
RAW MATERIAL COST(Y)
Grown by 8.94% (YoY
OPERATING PROFIT(Q)
Lowest at CNY 7.32 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 15.44 %
Here's what is working for Shanghai Hile Bio-Technology Co., Ltd.
Debt-Equity Ratio
Lowest at -33.48 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Shanghai Hile Bio-Technology Co., Ltd.
Net Sales
At CNY 85.52 MM has Grown at -45.29%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 9.17 MM has Fallen at -91.83%
over average net sales of the previous four periods of CNY 112.17 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 6.35 MM has Fallen at -92.12%
over average net sales of the previous four periods of CNY 80.62 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Profit
Lowest at CNY 7.32 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 15.44 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Raw Material Cost
Grown by 8.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at CNY 0.21 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income






